American Rhinologic Society Report issue

Foundation Phase 3

Organization Overview

First Clinical Trial
2010
NCT01197612
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

budesonide (rhinocort) (1 trial)

Drugs in Other Trials (1)

sodium tetradecyl sulfate (sotradecol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chronic Disease (Phase 3)

Colorectal Neoplasms (Phase 3)

Nasopharyngeal Neoplasms (Phase 3)

Sinusitis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2